Liraglutide in Treatment of Diabetes Mellitus Type 2: Systematic Review and Bibliometric Analysis Over The Last Two Decades

Background: Type 2 diabetes mellitus (T2DM) is a chronic progressive metabolic disorder and liraglutide is one of the glucagon-like peptide-1 (GLP-1) agonists that are used to decrease glucose levels in the blood and help in weight loss in patients with T2DM. Bibliometric analysis is one of the most common statistical methods used to evaluate the credibility, quality, and impact of scholarly work.